CURIS, INC. Number of Reporting Units
CURIS, INC. (CRIS) reported Number of Reporting Units of 1 segment for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Notes
us-gaap:NumberOfReportingUnits · last filed 2022-02-24
- CURIS, INC. number of reporting units for fiscal 2020 was 1.00 numberOfSecurities.
numberOfSecurities
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2020-12-31 | 1.00 numberOfSecurities 10-K · filed 2021-03-16 |
segment
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-24 |
| 2019-12-31 | 1.00 segment 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |